Center for Fetal Diagnosis and Treatment

ACTS recognizes N. Scott Adzick, MD, for Translation From Proof-of-Concept to Widespread Clinical Practice

A landmark study provides proof-of-concept for prenatal gene editing to potentially prevent congenital disease.

Scientists made strides in our approach to genetic tests, prenatal gene editing, type 1.5 diabetes, and more.

It has been a whirlwind week for most Americans, so if you need to break away from political news to catch up with your science news, you've come to the right place. This installment of In the News starts with an important study for patients with rare primary immunodeficiency diseases at risk of side effects from the rubella vaccine. Next,

This week we're all about getting smart in our highlights of research news from The Children's Hospital of Philadelphia. Getting smart in the approach to tackling childhood cancer means identifying strategies that will make a decade's progress in half the time - which is exactly the focus of the national Cancer Moonshot.

Hats off to N. Scott Adzick, MD, surgeon-in-chief and the founder and director of the Center for Fetal Diagnosis and Treatment at The Children’s Hospital of Philadelphia, on receiving Pennsylvania Bio’s Patient Impact Award at the organization’s annual dinner March 11.

Violence against children has reached an epidemic level globally, according to a new study published in the journal Pediatrics and reported by CBS News.

Fetal spina bifida surgery to repair myelomeningocele is a remarkable and intricate procedure performed before birth. If untreated, spinal cord damage from amniotic fluid exposure is progressive during gestation.